Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody
Open Access
- 18 December 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (51)
Abstract
Preventing autoantibody secretion by rendering self-reactive B cells functionally silent through clonal anergy has long posed the question of why fill the circulating B cell repertoire with cells that cannot secrete antibody? Here we address this question from the perspective of B cells that comprise 5 to 10% of the human circulating repertoire, expressing self-reactive surface immunoglobulins employing the IGHV4-34 heavy chain variable element. Using gene targeting to construct mice expressing a representative human IGHV4-34 antibody on the surface of many B cells, we show these cells are prevented from autoantibody secretion by B cell clonal anergy marked by downregulation of surface IgM, induction of tolerance-response mRNAs, and exclusion from the marginal zone and B1 cell subsets. This functionally tolerant state is overridden when the IGHV4-34 B cells cross-react with a virus, which stimulates the self-reactive B cells to hypermutate in germinal centers. Within 16 d of infection, 99% of daughter cells have acquired one of five heavy chain mutations that diminish binding to self but preserve virus binding, and 33% had combined 2 or 3 of these mutations to make their antibodies genetically self-tolerant and virus specific. These results demonstrate, from the perspective of a pathologically important human autoantibody class and the world’s most successful virus vaccine, how human antibody specificity is sculpted in the progeny of anergic B cells to yield antibodies that bind a virus but not self.Keywords
Funding Information
- DHAC | National Health and Medical Research Council (1113904)
- DHAC | National Health and Medical Research Council (2010134)
- DHAC | National Health and Medical Research Council (1183619)
- DHAC | National Health and Medical Research Council (2025529)
- DHAC | National Health and Medical Research Council (2008990)
This publication has 78 references indexed in Scilit:
- Uncontrolled CD21low age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpointCell Reports, 2022
- The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levelsAmerican Journal of Hematology, 2021
- Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell AnergyImmunity, 2009
- The V4-34 Encoded Anti-i Autoantibodies Recognize a Large Subset of Human and Mouse B-CellsBlood Cells, Molecules, and Diseases, 1996
- The I Binding Specificity of Human VH4-34 (VH4-21) Encoded Antibodies is Determined by Both VHFramework Region 1 and Complementarity Determining Region 3Journal of Molecular Biology, 1996
- Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selectionImmunity, 1995
- An anti‐B cell autoantibody from Wiskott‐Aldrich syndrome which recognizes i blood group specificity on normal human B cellsEuropean Journal of Immunology, 1992
- Evidence for the occurrence of O-glycosidically linked oligosaccharides of poly-N-acetyllactosamine type on the human leucocyte common antigenBiochemical and Biophysical Research Communications, 1983
- Blood group i and I activities of “lacto-N-norhexaosylceramide” and its analogues: The structural requirements for i-specificitiesBiochemical and Biophysical Research Communications, 1978
- REVERSIBLE AUTOHEMAGGLUTINATION WITH PERIPHERAL VASCULAR SYMPTOMSArchives of internal medicine (1960), 1937